Submission Details
| 510(k) Number | K200613 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 09, 2020 |
| Decision Date | April 15, 2020 |
| Days to Decision | 37 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K200613 is an FDA 510(k) clearance for the Tritanium? X TL Expandable Curved Posterior Lumbar Cage, a Intervertebral Fusion Device With Bone Graft, Lumbar (Class II — Special Controls, product code MAX), submitted by Stryker Corporation (Allendale, US). The FDA issued a Cleared decision on April 15, 2020, 37 days after receiving the submission on March 9, 2020. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3080.
| 510(k) Number | K200613 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 09, 2020 |
| Decision Date | April 15, 2020 |
| Days to Decision | 37 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MAX — Intervertebral Fusion Device With Bone Graft, Lumbar |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3080 |
| Definition | Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft. |